Acevedo, K., Masaldan, S., Opazo, C. M., & Bush, A. I. (2019). Redox active metals in neurodegenerative diseases. Journal of Biological Inorganic Chemistry, 24(8), 1141–1157.
Akyuz, E., Doganyigit, Z., Eroglu, E., Moscovicz, F., Merelli, A., Lazarowski, A., & Auzmendi, J. (2021). Myocardial iron overload in an experimental model of sudden unexpected death in epilepsy. Frontiers in Neurology, 12, 609236.
Article PubMed PubMed Central Google Scholar
Azadmanesh, M., Farkhondeh, T., Harifi-Mood, M. S., Aschner, M., Samini, F., & Samarghandian, S. (2025). Role of Nrf2 in epilepsy treatment. Current Molecular Medicine, 25(8), 980–990.
Balestrini, S., Arzimanoglou, A., Blumcke, I., Scheffer, I. E., Wiebe, S., Zelano, J., & Walker, M. C. (2021). The aetiologies of epilepsy. Epileptic Disorders, 23(1), 1–16.
Barker-Haliski, M., & White, H. S. (2015). Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harbor Perspectives in Medicine, 5(8), a022863.
Article PubMed PubMed Central Google Scholar
Cai, Y., & Yang, Z. (2021). Ferroptosis and its role in epilepsy. Frontiers in Cellular Neuroscience, 15, 696889.
Article PubMed PubMed Central Google Scholar
Carmona-Aparicio, L., Perez-Cruz, C., Zavala-Tecuapetla, C., Granados-Rojas, L., Rivera-Espinosa, L., Montesinos-Correa, H., Hernandez-Damian, J., Pedraza-Chaverri, J., Sampieri, A., Coballase-Urrutia, E., & Cardenas-Rodriguez, N. (2015). Overview of Nrf2 as therapeutic target in epilepsy. International Journal of Molecular Sciences, 16(8), 18348–18367.
Article PubMed PubMed Central Google Scholar
Chang, S. J., & Yu, B. C. (2010). Mitochondrial matters of the brain: Mitochondrial dysfunction and oxidative status in epilepsy. Journal of Bioenergetics and Biomembranes, 42(6), 457–459.
Chen, G. H., Song, C. C., Pantopoulos, K., Wei, X. L., Zheng, H., & Luo, Z. (2022). Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radical Biology and Medicine, 180, 95–107.
Chen, F., Kang, R., Liu, J., & Tang, D. (2023). The ACSL4 network regulates cell death and autophagy in diseases. Biology, 12(6), 864.
Article PubMed PubMed Central Google Scholar
Dang, Y., He, Q., Yang, S., Sun, H., Liu, Y., Li, W., Tang, Y., Zheng, Y., & Wu, T. (2022). FTH1- and SAT1-induced astrocytic ferroptosis is involved in alzheimer’s disease: Evidence from single-cell transcriptomic analysis. Pharmaceuticals, 15(10), 1177.
Article PubMed PubMed Central Google Scholar
Dionisio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021). Oxidative stress and regulated cell death in Parkinson’s disease. Ageing Research Reviews, 67, 101263.
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019). NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biology, 23, 101107.
Article PubMed PubMed Central Google Scholar
Domanskyi, A., & Parlato, R. (2022). Oxidative stress in neurodegenerative diseases. Antioxidants, 11(3), 504.
Article PubMed PubMed Central Google Scholar
Dorfmuller, G., & Delalande, O. (2013). Pediatric epilepsy surgery. Handbook of Clinical Neurology, 111, 785–795.
Engelborghs, S., D’Hooge, R., & De Deyn, P. P. (2000). Pathophysiology of epilepsy. Acta Neurologica Belgica, 100(4), 201–213.
Feng, L., Wang, C., Zhang, C., Zhang, W., Zhu, W., He, Y., Xia, Z., & Song, W. (2024). P38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model. Neural Regeneration Research, 19(10), 2299–2309.
Fine, A., & Wirrell, E. C. (2020). Seizures in children. Pediatrics in Review, 41(7), 321–347.
Fukui, M., Song, J. H., Choi, J., Choi, H. J., & Zhu, B. T. (2009). Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. European Journal of Pharmacology, 617(1–3), 1–11.
Geronzi, U., Lotti, F., & Grosso, S. (2018). Oxidative stress in epilepsy. Expert Review of Neurotherapeutics, 18(5), 427–434.
Grabarczyk, M., Justyńska, W., Czpakowska, J., Smolińska, E., Bielenin, A., Glabinski, A., & Szpakowski, P. (2024). Role of plant phytochemicals: Resveratrol, curcumin, luteolin and quercetin in demyelination, neurodegeneration, and epilepsy. Antioxidants, 13(11), 1364.
Article PubMed PubMed Central Google Scholar
Gruenbaum, B. F., Schonwald, A., Boyko, M., & Zlotnik, A. (2024). The role of glutamate and blood-brain barrier disruption as a mechanistic link between epilepsy and depression. Cells, 13(14), 1228.
Article PubMed PubMed Central Google Scholar
Guan, D. F., Ren, P. Y., Hu, W., & Zhang, Y. L. (2015). The mGluR5 positive allosteric modulator CDPPB inhibits SO2-induced protein radical formation and mitochondrial dysfunction through activation of Akt in mouse hippocampal HT22 cells. Cellular and Molecular Neurobiology, 35(4), 573–583.
Han, P., Wang, X., Zhou, T., Cheng, J., Wang, C., Sun, F., & Zhao, X. (2022). Inhibition of ferroptosis attenuates oligospermia in male Nrf2 knockout mice. Free Radical Biology & Medicine, 193(Pt 1), 421–429.
Handa, P., & Kowdley, K. V. (2016). A proton pump inhibitor a day keeps the iron away. Clinical Gastroenterology and Hepatology, 14(1), 153–155.
Hani, A. J., Mikati, H. M., & Mikati, M. A. (2015). Genetics of pediatric epilepsy. Pediatric Clinics of North America, 62(3), 703–722.
He, M., Liu, J., Cheng, S., Xing, Y., & Suo, W. Z. (2013). Differentiation renders susceptibility to excitotoxicity in HT22 neurons. Neural Regeneration Research, 8(14), 1297–1306.
Article PubMed PubMed Central Google Scholar
Huang, L., Xiao, W., Wang, Y., Li, J., Gong, J., Tu, E., Long, L., Xiao, B., Yan, X., & Wan, L. (2024). Metabotropic glutamate receptors (mGluRs) in epileptogenesis: An update on abnormal mGluRs signaling and its therapeutic implications. Neural Regeneration Research, 19(2), 360–368.
Jin, M. L., Park, S. Y., Kim, Y. H., Oh, J. I., Lee, S. J., & Park, G. (2014). The neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells. Neurotoxicology, 41, 102–111.
Katyayan, A., & Diaz-Medina, G. (2021). Epilepsy: Epileptic syndromes and treatment. Neurologic Clinics, 39(3), 779–795.
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., Smith, S. B., Ganapathy, V., & Maher, P. (2013). The cystine/glutamate antiporter system xc-in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxidants & redox signaling, 18(5), 522–555.
Li, L., Lin, G., Gu, H., Yu, L., & Ni, C. (2019). Effects of Srxn1 on growth and Notch signalling of astrocyte induced by hydrogen peroxide. Artificial Cells, Nanomedicine and Biotechnology, 47(1), 1917–1923.
Li, J., Jia, B., Cheng, Y., Song, Y., Li, Q., & Luo, C. (2022). Targeting molecular mediators of ferroptosis and oxidative stress for neurological disorders. Oxidative Medicine and Cellular Longevity, 2022, 3999083.
Article PubMed PubMed Central Google Scholar
Li, W., Wu, J., Zeng, Y., & Zheng, W. (2023). Neuroinflammation in epileptogenesis: From pathophysiology to therapeutic strategies. Frontiers in Immunology, 14, 1269241.
Article PubMed PubMed Central Google Scholar
Lin, Z., Liu, J., Kang, R., Yang, M., & Tang, D. (2021). Lipid metabolism in ferroptosis. Advanced Biology, 5(8), e2100396.
Comments (0)